1993
DOI: 10.1016/s0040-4039(00)60572-5
|View full text |Cite
|
Sign up to set email alerts
|

Automated incorporation of polyethylene glycol into synthetic oligonucleotides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
1

Year Published

1995
1995
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(26 citation statements)
references
References 12 publications
1
24
0
1
Order By: Relevance
“…The method allows charge-specic graing of hydrophilic PEG molecules onto the DNA backbone, unlike previously reported chemical modication to obtain DNA-PEG conjugates. 21,[71][72][73][74] The noncovalent approach for PEGylation of oligonucleotides described here can potentially be considered as a third generation PEGylation approach in relation to the existing methods. 75,76 The process renders metal-free DNA molecules.…”
Section: Discussionmentioning
confidence: 99%
“…The method allows charge-specic graing of hydrophilic PEG molecules onto the DNA backbone, unlike previously reported chemical modication to obtain DNA-PEG conjugates. 21,[71][72][73][74] The noncovalent approach for PEGylation of oligonucleotides described here can potentially be considered as a third generation PEGylation approach in relation to the existing methods. 75,76 The process renders metal-free DNA molecules.…”
Section: Discussionmentioning
confidence: 99%
“…Jäschke et al have developed a suite of PEG-modified phosphoramidites and controlled pore glass (CPG) to incorporate PEG into 5′, 3′, or internal positions of ONs through automated DNA synthesis (Fig. 1(a)) [64, 65]. A large library of PEGylated ONs with different PEG M W (400 Da to 4 kDa) and conjugation sites has been successfully prepared.…”
Section: Pegylation Of Ons Using Linear or Slightly Branched Pegmentioning
confidence: 99%
“…One way to tackle these problems is to functionalize pharmaceutically active nucleic acids with PEG. [93] Direct coupling of PEG [90] or coupling through a linker molecule [91] has resulted in increased stability of oligonucleotides towards enzymatic degradation, prolonged plasma permanence, and enhanced penetration into cells by masking the negative charges of ODNs. One DBC drug already commercialized in 2004 is a PEGylated 28-mer aptamer, PEG-aptanib, which was approved by the FDA for the treatment of age-related macular degeneration of the retina.…”
Section: Biomedicinementioning
confidence: 99%